Mycobacteria and allergies

Immunobiology

Volumn 212, Issue 6, 2007, Pages 461-473

  Rook, Graham A W ^a   Hamelmann, Eckard ^b   Rosa Brunet, L ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allergy; Hygiene Hypothesis; Mycobacteria; Tuberculosis; Vaccination

Indexed keywords

ALLERGEN; BCG VACCINE; CHAPERONIN; HOUSE DUST ALLERGEN; INTERLEUKIN 10; INTERLEUKIN 4; LIPOARABINOMANNAN; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TUBERCULIN; WATER;

ALLERGIC DISEASE; ALLERGY; ANIMAL MODEL; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BCG VACCINATION; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; HUMAN; HYGIENE; IMMUNE RESPONSE; IMMUNOLOGY; IMMUNOREGULATION; IMMUNOTHERAPY; INNATE IMMUNITY; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM VACCAE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SOIL MICROFLORA; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TUBERCULIN TEST; TUBERCULOSIS;

EID: 34249743203     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.03.003     Document Type: Article

References (94)

1. Abel B., Thieblemont N., Quesniaux V.J., Brown N., Mpagi J., Miyake K., Bihl F., and Ryffel B. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169 (2002) 3155-3162
2. Adams J.F., Scholvinck E.H., Gie R.P., Potter P.C., Beyers N., and Beyers A.D. Decline in total serum IgE after treatment for tuberculosis. Lancet 353 (1999) 2030-2033
3. Adams V.C., Hunt J.R., Martinelli R., Palmer R., Rook G.A., and Brunet L.R. Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice. Eur. J. Immunol. 34 (2004) 631-638
4. Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., Crameri R., Thunberg S., Deniz G., Valenta R., Fiebig H., Kegel C., Disch R., Schmidt-Weber C.B., Blaser K., and Akdis C.A. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199 (2004) 1567-1575
5. Alm J.S., Lilja G., Pershagen G., and Scheynius A. Early BCG vaccination and development of atopy. Lancet 350 (1997) 400-403
6. Andersen P., and Doherty T.M. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3 (2005) 656-662
7. Annus T., Montgomery S.M., Riikjarv M.A., and Bjorksten B. Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination. Allergy 59 (2004) 1068-1073
8. Arikan C., Bahceciler N.N., Deniz G., Akdis M., Akkoc T., Akdis C.A., and Barlan I.B. Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin. Exp. Allergy 34 (2004) 398-405
9. Arkwright P.D., and David T.J. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J. Allergy Clin. Immunol. 107 (2001) 531-534
10. Arkwright P.D., and David T.J. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. Br. J. Dermatol. 149 (2003) 1029-1034
11. Baily G.V. Tuberculosis prevention trial, Madras. Indian J. Med. Res. 72 Suppl. (1980) 1-74
12. Bibakis I., Zekveld C., Dimitroulis I., Pedioti A., Gerakianaki T., Fanourgiaki S., Kokiadi I., Iliakou-Bibakis V., Newman Taylor A.J., Stanford C.A., Stanford J.L., and Cullinan P. Childhood atopy and allergic disease and skin test responses to environmental mycobacteria in rural Crete: a cross-sectional survey. Clin. Exp. Allergy 35 (2005) 624-629
13. Black G.F., Dockrell H.M., Crampin A.C., Floyd S., Weir R.E., Bliss L., Sichali L., Mwaungulu L., Kanyongoloka H., Ngwira B., Warndorff D.K., and Fine P.E. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J. Infect. Dis. 184 (2001) 322-329
14. Black G.F., Fine P.E.M., Warndorff D.K., Floyd S., Weir R.E., Blackwell J.M., Bliss L., Sichali L., Mwaungulu L., Chaguluka S., Jarman E., Ngwira B., and Dockrell H.M. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int. J. Tuberc. Lung Dis. 5 (2001) 664-672
15. Bochud P.Y., Hawn T.R., and Aderem A. Cutting edge: a toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 170 (2003) 3451-3454
16. Boussiotis V.A., Tsai E.Y., Yunis E.J., Thim S., Delgado J.C., Dascher C.C., Berezovskaya A., Rousset D., Reynes J.M., and Goldfeld A.E. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105 (2000) 1317-1325
17. Briken V., Moody D.B., and Porcelli S.A. Diversification of CD1 proteins: sampling the lipid content of different cellular compartments. Semin. Immunol. 12 (2000) 517-525
18. Camporota L., Corkhill A., Long H., Lordan J., Stanciu L., Tuckwell N., Cross A., Stanford J.L., Rook G.A., Holgate S.T., and Djukanovic R. The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur. Respir. J. 21 (2003) 287-293
19. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., and Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197 (2003) 403-411
20. Choi I.S., and Koh Y.I. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann. Allergy Asthma Immunol. 88 (2002) 584-591
21. Choi I.S., and Koh Y.I. Effects of BCG revaccination on asthma. Allergy 58 (2003) 1114-1116
22. Choi I.S., Lin X.H., Koh Y.A., Koh Y.I., and Lee H.C. Strain-dependent suppressive effects of BCG vaccination on asthmatic reactions in BALB/c mice. Ann. Allergy Asthma Immunol. 95 (2005) 571-578
23. da Cunha S.S., Cruz A.A., Dourado I., Barreto M.L., Ferreira L.D., and Rodrigues L.C. Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG. Allergy 59 (2004) 857-862
24. De Heer H.J., Hammad H., Soullie T., Hijdra D., Vos N., Willart M.A., Hoogsteden H.C., and Lambrecht B.N. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200 (2004) 89-98
25. Delgado J.C., Tsai E.Y., Thim S., Baena A., Boussiotis V.A., Reynes J.M., Sath S., Grosjean P., Yunis E.J., and Goldfeld A.E. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc. Natl. Acad. Sci. USA 99 (2002) 7576-7581
26. Demissie A., Abebe M., Aseffa A., Rook G., Fletcher H., Zumla A., Weldingh K., Brock I., Andersen P., Doherty T.M., and The VACSEL Study Group. Healthy individuals that control a latent infection with M. tuberculosis express high levels of Th-1 cytokines and the IL-4 antagonist IL-4d2. J. Immunol. 172 (2004) 6938-6943
27. Duchmann R., Kaiser I., Hermann E., Mayet W., Ewe K., and Meyer zum Buschenfelde K.H. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102 (1995) 448-455
28. Ellertsen L.K., Wiker H.G., Egeberg N.T., and Hetland G. Allergic sensitisation in tuberculosis and leprosy patients. Int. Arch. Allergy Immunol. 138 (2005) 217-224
29. Erb K.J., Holloway J.W., Sobeck A., Moll H., and Le Gros G. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 187 (1998) 561-569
30. Fine P.E., Sterne J.A.C., Ponnighaus J.M., and Rees R.J.W. Delayed type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344 (1994) 1245-1249
31. Fiorenza G., Rateni L., Farroni M.A., Bogue C., and Dlugovitzky D.G. TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol. Lett. 98 (2005) 45-48
32. Fletcher H.A., Owiafe P., Jeffries D., Hill P., Rook G.A.W., Zumla A., Doherty T.M., Brookes R., and VACSEL Study Group. Increased expression of mRNA encoding IL-4 and its splice variant IL-4d2 in cells from contacts of Mycobacterium tuberculosis in the absence of in vitro stimulation. Immunology 112 (2004) 669-673
33. Floyd S., Ponnighaus J.M., Bliss L., Nkhosa P., Sichali L., Msiska G., and Fine P.E. Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guerin vaccination in northern Malawi. J. Infect. Dis. 186 (2002) 807-814
34. Fujimura Y. Functional morphology of microfold cells (M cells) in Peyer's patches - phagocytosis and transport of BCG by M cells into rabbit Peyer's patches. Gastroenterol. Jpn. 21 (1986) 325-335
35. Gruber C., Meinlschmidt G., Bergmann R., Wahn U., and Stark K. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr. Allergy Immunol. 13 (2002) 177-181
36. Guerkov R.E., Targoni O.S., Kreher C.R., Boehm B.O., Herrera M.T., Tary-Lehmann M., Lehmann P.V., and Schwander S.K. Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J. Immunol. Methods 279 (2003) 111-121
37. Gutierrez M.C., Brisse S., Brosch R., Fabre M., Omais B., Marmiesse M., Supply P., and Vincent V. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog. 1 (2005) e5
38. Guyot-Revol V., Innes J.A., Hackforth S., Hinks T., and Lalvani A. Regulatory T cells are expanded in blood and disease sites in tuberculosis patients. Am. J. Respir. Crit. Care Med. 173 (2006) 803-810
39. Hadley E.A., Smillie F.I., Turner M.A., Custovic A., Woodcock A., and Arkwright P.D. Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis. Clin. Exp. Immunol. 140 (2005) 101-108
40. Hansen G., Berry G., DeKruyff R.H., and Umetsu D.T. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103 (1999) 175-183
41. Heldwein K.A., and Fenton M.J. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 4 (2002) 937-944
42. Herz U., Gerhold K., Gruber C., Braun A., Wahn U., Renz H., and Paul K. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J. Allergy Clin. Immunol. 102 (1998) 867-874
43. Hessel E.M., Chu M., Lizcano J.O., Chang B., Herman N., Kell S.A., Wills-Karp M., and Coffman R.L. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J. Exp. Med. 202 (2005) 1563-1573
44. Hopfenspirger M.T., and Agrawal D.K. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J. Immunol. 168 (2002) 2516-2522
45. Hopkin J.M. New drugs for asthma, allergy and COPD. In: Hansel T.T., and Barnes P.J. (Eds). Progress Respiratory Research vol. 31 (2001), Karger, Basel 226-228
46. Hunt J.R., Martinelli R., Adams V.C., Rook G.A.W., and Rosa Brunet L. Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model. Clin. Exp. Allergy 35 (2005) 685-690
47. Kang T.J., Lee S.B., and Chae G.T. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 20 (2002) 56-62
48. Karlsson M.R., Rugtveit J., and Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J. Exp. Med. 199 (2004) 1679-1688
49. Kraus T.A., Toy L., Chan L., Childs J., and Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 126 (2004) 1771-1778
50. Kriegel M.A., Lohmann T., Gabler C., Blank N., Kalden J.R., and Lorenz H.M. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199 (2004) 1285-1291
51. Marks G.B., Ng K., Zhou J., Toelle B.G., Xuan W., Belousova E.G., and Britton W.J. The effect of neonatal BCG vaccination on atopy and asthma at age 7-14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J. Allergy Clin. Immunol. 111 (2003) 541-549
52. Matricardi P.M., and Yazdanbakhsh M. Mycobacteria and atopy, 6 years later: a fascinating, still unfinished, business. Clin. Exp. Allergy 33 (2003) 717-720
53. Morr M., Takeuchi O., Akira S., Simon M.M., and Muhlradt P.F. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur. J. Immunol. 32 (2002) 3337-3347
54. Obihara C.C., Beyers N., Gie R.P., Potter P.C., Marais B.J., Lombard C.J., Enarson D.A., and Kimpen J.L. Inverse association between Mycobacterium tuberculosis infection and atopic rhinitis in children. Allergy 60 (2005) 1121-1125
55. Obihara C.C., Kimpen J.L., Gie R.P., Lill S.W., Hoekstra M.O., Marais B.J., Schaaf H.S., Lawrence K., Potter P.C., Bateman E.D., Lombard C.J., and Beyers N. Mycobacterium tuberculosis infection may protect against allergy in a tuberculosis endemic area. Clin. Exp. Allergy 36 (2006) 70-76
56. Ota M.O., van der Sande M.A., Walraven G.E., Jeffries D., Nyan O.A., Marchant A., and McAdam K.P. Absence of association between delayed type hypersensitivity to tuberculin and atopy in children in The Gambia. Clin. Exp. Allergy 33 (2003) 731-736
57. Ozdemir C., Akkoc T., Bahceciler N.N., Kucukercan D., Barlan I.B., and Basaran M.M. Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma. Clin. Exp. Allergy 33 (2003) 266-270
58. Powrie F., Read S., Mottet C., Uhlig H., and Maloy K. Control of immune pathology by regulatory T cells. Novartis Found. Symp. 252 (2003) 92-98
59. Rainey F.A., Klatte S., Kroppenstedt R.M., and Stackebrandt E. Dietzia, a new genus including Dietzia maris comb. nov., formerly Rhodococcus maris. Int. J. Syst. Bacteriol. 45 (1995) 32-36
60. Reiling N., Holscher C., Fehrenbach A., Kroger S., Kirschning C.J., Goyert S., and Ehlers S. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169 (2002) 3480-3484
61. Richeldi L., Ewer K., Losi M., Bergamini B.M., Roversi P., Deeks J., Fabbri L.M., and Lalvani A. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am. J. Respir. Crit. Care Med. 170 (2004) 288-295
62. Riffo-Vasquez Y., Spina D., Page C., Tormay P., Singh M., Henderson B., and Coates A. Effect of Mycobacterium tuberculosis chaperonins on bronchial eosinophilia and hyper-responsiveness in a murine model of allergic inflammation. Clin. Exp. Allergy 34 (2004) 712-719
63. Rook G.A.W., and Stanford J.L. Give us this day our daily germs. Immunol. Today 19 (1998) 113-116
64. Rook G.A., Adams V., Hunt J., Palmer R., Martinelli R., and Brunet L.R. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin. Immunopathol. 25 (2004) 237-255
65. Rook G., Dheda K., and Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?. Vaccine 23 (2005) 2115-2120
66. Rook G.A., Dheda K., and Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev. Immunol. 5 (2005) 661-667
67. Sayers I., Severn W., Scanga C.B., Hudson J., Le Gros G., and Harper J.L. Suppression of allergic airway disease using mycobacterial lipoglycans. J. Allergy Clin. Immunol. 114 (2004) 302-309
68. Seya T., Matsumoto M., Tsuji S., Begum N.A., Azuma I., and Toyoshima K. Structural-functional relationship of pathogen-associated molecular patterns: lessons from BCG cell wall skeleton and mycoplasma lipoprotein M161Ag. Microbes Infect. 4 (2002) 955-961
69. Shirakawa T., Enomoto T., Shimazu S., and Hopkin J.M. The inverse association between tuberculin responses and atopic disorder. Science 275 (1996) 77-79
70. Shirtcliffe P.M., Goldkorn A., Weatherall M., Tan P.L., and Beasley R. Pilot study of the safety and effect of intranasal delipidated acid-treated Mycobacterium vaccae in adult asthma. Respirology 8 (2003) 497-503
71. Shirtcliffe P.M., Easthope S.E., Weatherall M., and Beasley R. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guerin in adult asthma. Clin. Exp. Allergy 34 (2004) 207-212
72. Smit J.J., Van Loveren H., Hoekstra M.O., Schijf M.A., Folkerts G., and Nijkamp F.P. Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features. Clin. Exp. Allergy 33 (2003) 1083-1089
73. Stanford J.L., Ganapati R., Revankar C.R., Lockwood D., Price J., Ashton P., Ashton L., and Rees R.J. Sensitisation by mycobacteria and the effects of BCG on children attending schools in the slums of Bombay. Tubercle 69 (1988) 293-298
74. Stene L.C., and Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet 357 (2001) 607
75. Stenger S., and Modlin R.L. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr. Opin. Immunol. 14 (2002) 452-457
76. Stock P., Akbari O., Berry G., Freeman G.J., Dekruyff R.H., and Umetsu D.T. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 5 (2004) 1149-1156
77. Strachan D.P. Hay fever, hygiene, and household size. BMJ 299 (1989) 1259-1260
78. Strannegard I.L., Larsson L.O., Wennergren G., and Strannegard O. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 53 (1998) 249-254
79. Suemura M., Ishizaka A., Kobatake S., Sugimura K., Maeda K., Nakanishi K., Kishimoto S., Yamamura Y., and Kishimoto T. Inhibition of IgE production in B hybridomas by IgE class-specific suppressor factor from T hybridomas. J. Immunol. 130 (1983) 1056-1060
80. Sutmuller R.P., den Brok M.H., Kramer M., Bennink E.J., Toonen L.W., Kullberg B.J., Joosten L.A., Akira S., Netea M.G., and Adema G.J. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116 (2006) 485-494
81. Suzuki N., Kudo K., Sano Y., and Ito K. Can Mycobacterium tuberculosis infection prevent asthma and other allergic disorders?. Int. Arch. Allergy Immunol. 124 (2001) 113-116
82. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., and Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169 (2002) 10-14
83. Toossi Z., and Ellner J.J. The role of TGF beta in the pathogenesis of human tuberculosis. Clin. Immunol. Immunopathol. 87 (1998) 107-114
84. Townley R.G., Barlan I.B., Patino C., Vichyanond P., Minervini M.C., Simasathien T., Nettagul R., Bahceciler N.N., Basdemir D., Akkoc T., Pongprueksa S., and Hopp R.J. The effect of BCG vaccine at birth on the development of atopy or allergic disease in young children. Ann. Allergy Asthma Immunol. 92 (2004) 350-355
85. Umetsu D.T., McIntire J.J., and DeKruyff R.H. TIM-1, hepatitis A virus and the hygiene theory of atopy: association of TIM-1 with atopy. J. Pediatr. Gastroenterol. Nutr. 40 Suppl. 1 (2005) S43
86. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971-979
87. von Mutius E., Pearce N., Beasley R., Cheng S., von Ehrenstein O., Bjorksten B., and Weiland S. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 55 (2000) 449-453
88. Wang C.C., and Rook G.A.W. Inhibition of an established allergic response to ovalbumin in Balb/c mice by killed Mycobacterium vaccae. Immunology 93 (1998) 307-313
89. Weir R.E., Fine P.E., Nazareth B., Floyd S., Black G.F., King E., Stanley C., Bliss L., Branson K., and Dockrell H.M. Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin. Exp. Immunol. 134 (2003) 285-294
90. Wildin R.S., Smyk-Pearson S., and Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39 (2002) 537-545
91. Wills-Karp M., Santeliz J., and Karp C.L. The germless theory of allergic disease; revisiting the hygiene hypothesis. Nat. Rev. 1 (2001) 69-75
92. Zhao X.Y., Xie Q.M., Chen J.Q., and Bian R.L. [Effects of vaccae on airway contraction and inflammation in asthmatic guinea pigs]. Zhonghua Jie He He Hu Xi Za Zhi 26 (2003) 218-222
93. Zuany-Amorim C., Manlius C., Trifilieff A., Brunet L.R., Rook G., Bowen G., Pay G., and Walker C. Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J. Immunol. 169 (2002) 1492
94. Zuany-Amorim C., Sawicka E., Manlius C., Le Moine A., Brunet L.R., Kemeny D.M., Bowen G., Rook G., and Walker C. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8 (2002) 625-629